Alpha-Lipoic Acid Plus N-Acetylcysteine with Nicotinamide Riboside
Alpha-Lipoic Acid Plus N-Acetylcysteine with Nicotinamide Riboside, NPN 80133193: natural health product licensed in Canada. Medicinal ingredients: Pyridinium, 3-(aminocarbonyl)-1-bêta-D-ribofuranosyl-, Acide L-alpha-acétamido-bêta-mercaptopropionique.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Pyridinium, 3-(aminocarbonyl)-1-bêta-D-ribofuranosyl- Source : Chlorure de nicotinamide riboside | 300 mg | Not calculated |
| Acide L-alpha-acétamido-bêta-mercaptopropionique Source : N-Acétyl-L-cystéine | 600 mg | Not calculated |
Non-medicinal ingredients
Trehalose, Hydroxypropyle Cyclodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 2 Cuillère à café | 1 Tous les jours |
Uses authorised in Canada
Helps to promote healthy glucose metabolism. Source of/Provides antioxidants.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contra-Indications
Do not use this product if you are taking antibiotics or nitroglycerin.
- Cautions and Warnings
Ask a health care practitioner/health care provider/health care professional/doctor/ physician before use if you have diabetes. Stop use and ask a health care practitioner/health care provider/health care professional/ doctor/physician if you experience sweating, paleness, chills, headache, dizziness and/or confusion (as these may be symptoms of serious low blood sugar) Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are pregnant, breastfeeding or have kidney stones.
Product record
- Licence holder
- LeralabInc
- NPN or DIN-HM
- 80133193
- Status
- Active licence
- Licence date
- 7 August 2024
- Revision date
- Not provided
- Form
- Poudre pour solution
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
Source
Official Health Canada record, licence 80133193
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Alpha-Lipoic Acid Plus N-Acetylcysteine with Nicotinamide Riboside (LeralabInc): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80133193-alpha-lipoic-acid-plus-n-acetylcysteine-with-nicotinamide-ri, updated 7 August 2024.